These Eli Lilly executives have been scooping up stock after its big dropBy Mario Cazombo / August 12, 2025 Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
